Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
ON Semiconductor
ON
$31.8B
| $36.5M | 0.05% |
579,296
+174,800
| +43% | +$12M |
|
427
REX American Resources
REX
$1.44B
| $36.5M | 0.05% |
1,752,006
+42,976
| +3% | +$950K |
|
428
Ituran Location and Control
ITRN
$1.05B
| $36.4M | 0.05% |
1,169,300
-1,500
| -0.1% | -$42.6K |
|
429
Sysco
SYY
$40B
| $36.3M | 0.05% |
475,200
-442,600
| -48% | -$33.9M |
|
|
PRMB
430
Primo Brands
PRMB
$8.99B
| $36.3M | 0.05% |
+1,179,423
| New | +$35M |
|
431
Flowserve
FLS
$10.3B
| $36.1M | 0.05% |
627,200
-6,000
| -0.9% | -$344K |
|
432
Oscar Health
OSCR
$9.44B
| $36M | 0.05% |
2,677,673
-886,427
| -25% | -$14.3M |
|
433
Cellebrite
CLBT
$2.63B
| $35.9M | 0.05% |
1,630,439
+115,939
| +8% | +$2.23M |
|
434
Canadian National Railway
CNI
$77.2B
| $35.8M | 0.05% |
352,900
+294,200
| +501% | +$32.2M |
|
435
A10 Networks
ATEN
$1.97B
| $35.6M | 0.05% |
1,933,307
-15,626
| -0.8% | -$255K |
|
436
Fidelity National Information Services
FIS
$22.8B
| $35.1M | 0.05% |
+434,242
| New | +$37.4M |
|
437
Powell Industries
POWL
$7.48B
| $35M | 0.05% |
474,105
-534,900
| -53% | -$47.8M |
|
438
Allegion
ALLE
$14.2B
| $35M | 0.05% |
267,700
+218,000
| +439% | +$30.8M |
|
439
Aecom
ACM
$8.17B
| $34.9M | 0.05% |
326,477
-198,700
| -38% | -$21.7M |
|
440
Clover Health Investments
CLOV
$2.37B
| $34.9M | 0.05% |
11,066,600
-1,413,300
| -11% | -$5.05M |
|
441
Lumentum
LITE
$77.8B
| $34.7M | 0.05% |
413,838
+347,600
| +525% | +$27.1M |
|
442
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $34.6M | 0.05% |
328,300
-169,100
| -34% | -$17.9M |
|
443
Snap-on
SNA
$20.9B
| $34.6M | 0.05% |
101,900
-54,100
| -35% | -$18.3M |
|
444
National Bank Holdings
NBHC
$1.94B
| $34.6M | 0.05% |
803,200
-29,600
| -4% | -$1.34M |
|
445
Expedia Group
EXPE
$39.5B
| $34.5M | 0.05% |
184,893
+60,800
| +49% | +$10.5M |
|
446
Axalta
AXTA
$7.94B
| $34.4M | 0.05% |
1,004,300
-66,000
| -6% | -$2.48M |
|
447
UGI
UGI
$7.57B
| $34.3M | 0.05% |
1,216,583
+313,000
| +35% | +$8.12M |
|
448
MSC Industrial Direct
MSM
$6.75B
| $34.3M | 0.05% |
459,100
+54,600
| +13% | +$4.5M |
|
449
Starbucks
SBUX
$124B
| $33.7M | 0.05% |
+369,784
| New | +$35.8M |
|
450
JetBlue
JBLU
$2.18B
| $33.6M | 0.05% |
4,274,457
+3,552,057
| +492% | +$24.1M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.